A longtime leader in healthcare improvement, we’re developing new ways to revolutionize the industry.
We are honored to provide technology and services to help providers thrive, and that the HFMA panel awarded our solution Peer Review designation.
The future of life sciences is hurtling towards a digital revolution with emphasis on immediacy for the pharmaceutical, biopharmaceutical, and medical device technology value chain.
The power of RWD and RWE continues to play a key role in helping increase research efficiency and accelerate the introduction of new treatments.
Value-based care can help give providers flexibility to innovate care and holds them accountable for clinical outcomes and cost of treating an entire population.
Automated buying experience with complete visibility into procurement will help drive healthcare supply chain resiliency, savings opportunities and quality patient care across the care continuum.
More and more researchers are turning to actionable insights derived from the PINC AI™ Healthcare Database to further knowledge about cancer.
Premier's Karen Niven highlights the essential role of change management in successful healthcare value analysis programs.
bioMérieux and PINC AI™ Applied Sciences collaborate to understand the epidemiology, HRU and costs related to AGE in adult patients.
Watch this on-demand webinar to learn more about how these proposed payment and quality policies could impact your organization in the coming fiscal year.
Premier, Inc. announced that its Board of Directors is evaluating potential strategic alternatives to enhance value for stockholders.
Premier’s Chief Pharmacy Officer Jessica Daley joins a panel of experts to discuss strategies to manage and mitigate drug shortages.